Pharmaceutical News

RSS

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

A recent research paper posted to the bioRxiv* preprint server demonstrated that a cocktail of two synergetic antibodies extensively neutralized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including Omicron BA.1 and BA.2.

1 May 2022

At US hospitals, a drug mix-up is just a few keystrokes away

More than four years ago, Tennessee nurse RaDonda Vaught typed two letters into a hospital's computerized medication cabinet, selected the wrong drug from the search results, and gave a patient a fatal dose.

29 Apr 2022

Emergency contraception marks a new battle line in Texas

"Mysterious Dolphin" needed an emergency contraception pill dropped off on a porch outside of town.

28 Apr 2022

Nearly 60% of Americans infected by Omicron

A recent study published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced viral antibodies (Abs) seroprevalence in the United States (US).

28 Apr 2022

Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?

A new study published in the journal Vaccines evaluated if re-freezing coronavirus disease 2019 (COVID-19) mRNA vaccine vials preserved the immunogenicity.

27 Apr 2022

Research highlights importance of booster vaccine doses to protect against all Omicron variants

In a recent study published in the Cell Host and Microbe journal, researchers examined the neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, BA.1.1, and BA.2 sublineages.

27 Apr 2022

Fourth dose of COVID vaccine in over 60 years significantly effective

In a recent study published in the Nature Medicine journal, the researchers assessed the effectiveness of a second booster dose of the BioNTech, Pfizer BNT162b2 vaccine against coronavirus disease 2019 (COVID-19) severity in elderly patients.

26 Apr 2022

Well-established group of antimalarials unlikely to be affected by resistance, study shows

New research published today in Antimicrobial Agents and Chemotherapy, shows that the well-established group of antimalarials, known as artemisinins, are unlikely to be affected by resistance.

26 Apr 2022

New drug combo emerges as a potential candidate for oral pericoital contraception

A new combination of drugs has emerged as a "promising candidate" for an on-demand contraceptive pill, suggests preliminary research published online in the journal BMJ Sexual & Reproductive Health.

26 Apr 2022

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant immune-mediated hepatitis.

25 Apr 2022

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Researchers investigate the duration of effectiveness of mRNA-based COVID-19 vaccines in preventing ICU admission.

21 Apr 2022

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

20 Apr 2022

Radioconjugates could transform the future of cancer care

Many current cancer treatments make patients very sick because even the most targeted treatments kill healthy cells as well as cancer cells. But a new type of treatment called a radioconjugate is getting the attention of oncologists.

20 Apr 2022

Antidepressant use is not related to better health-related quality of life in the long run

Over time, using antidepressants is not associated with significantly better health-related quality of life, compared to people with depression who do not take the drugs.

20 Apr 2022

Disasters can disrupt access to medications for opioid use disorder in vulnerable communities

The COVID-19 pandemic has spiked the overdose death rate from opioid use. For people who rely on medications (buprenorphine, methadone, and extended-release naltrexone) to treat opioid use disorders, the pandemic and such natural disasters as tornados, hurricanes, and wildfires can disrupt access to medications.

20 Apr 2022

Why cheap, older drugs that might treat covid never get out of the lab

In March 2020, Dr. Joseph Vinetz left the contemplative world of his Yale University infectious-disease laboratory and plunged into the covid ward at Yale New Haven Hospital, joining an army of health care workers who struggled to treat the deadly viral disease.

19 Apr 2022

New research on immune correlates for Janssen Ad26.Cov2.S COVID vaccine

Previous
1
...
80
81
82
83
84
85
86
...
1434
Next

Pharmaceutical News

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

At US hospitals, a drug mix-up is just a few keystrokes away

Emergency contraception marks a new battle line in Texas

Nearly 60% of Americans infected by Omicron

Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?

Research highlights importance of booster vaccine doses to protect against all Omicron variants

Fourth dose of COVID vaccine in over 60 years significantly effective

Well-established group of antimalarials unlikely to be affected by resistance, study shows

New drug combo emerges as a potential candidate for oral pericoital contraception

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

Monoclonal-antibody combination AZD7442 prevents COVID-19

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Radioconjugates could transform the future of cancer care

Antidepressant use is not related to better health-related quality of life in the long run

Disasters can disrupt access to medications for opioid use disorder in vulnerable communities

Why cheap, older drugs that might treat covid never get out of the lab

New research on immune correlates for Janssen Ad26.Cov2.S COVID vaccine

Study examines how race and sex influence tacrolimus pharmacokinetics in kidney transplant recipients

4th dose of mRNA Covid-19 vaccine significantly increases protection in age 60+

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News